Par Pharmaceuticals
TIGAN
Manufacturer:
Par Pharmaceuticals
Name:
TIGAN
HCPCS Code Descriptor:
Injection, trimethobenzamide hcl, up to 200 mg
Category:
J Code
HCPCS:
J3250
NDC(s):
42023-0119-25
Primary Type:
Oncology-Anti-Emetic
Generic Status:
Single-Source
Route of Administration:
Intramuscular
About:
TIGAN is an Oncology-Anti-Emetic drug manufactured by Par Pharmaceuticals and administered via the Intramuscular route of administration. The J Code: J3250 is aligned to the drug TIGAN.